Absorption of three wine-related polyphenols in three different matrices by healthy subjects.
By D. Goldberg, Joe Yan, G. Soleas. Clinical Biochemistry, 2003
696 citations recorded by the source corpus.
Subfields: Biochemistry, Geriatrics and Gerontology, Pathology and Forensic Medicine
View Paper: https://www.semanticscholar.org/paper/e0ee42cfda2e7c711b65cb36d3c07dfee519a813
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Biochemistry
In Geriatrics and Gerontology
In Pathology and Forensic Medicine
Citations in the corpus
- Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. (2005, background): “Thus, it is not a simple matter to extrapolate the results of yeast studies to human health, especially when the studies on yeast used much higher concentrations of resveratrol than are available from wine drinking [94], and its poor bioavailability after metabolization [41, 51, 54, 61].”
- Properties of Resveratrol: In Vitro and In Vivo Studies about Metabolism, Bioavailability, and Biological Effects in Animal Models and Humans (2015, background): “[49] In vivo: human Oral: 25mg Once 10 to 40 nmol/L NO In vitro anticancer and anti-inflammatory effects of the free polyphenols are irrelevant in vivo”
- HIGH ABSORPTION BUT VERY LOW BIOAVAILABILITY OF ORAL RESVERATROL IN HUMANS (2004, methodology): “dose) and using a sensitive gas chromatography/MS methodology (Goldberg et al., 2003).”
- Resveratrol and health--a comprehensive review of human clinical trials. (2011, background): “The absorption and metabolism of resveratrol appear to be broadly similar to that of other polyphenols such as quercetin and catechin [25], although a number of factors may influence the pharmacokinetics of each.”
- Cancer Chemoprevention Through Dietary Antioxidants: Progress and Promise (2008, positive): “Results from preclinical studies in rats, using high-performance liquid chromatography meth-ods, suggest consistent attainment of plasma peak levels 5–10 min post-oral administration and a rapid plasma elimination half-life of 12–15 min (94).”
- A critical review of the data related to the safety of quercetin and lack of evidence of in vivo toxicity, including lack of genotoxic/carcinogenic properties. (2007, background): “, vegetable juice, white wine, or grape juice), mean plasma aglycone levels of up to 25 ng/mL were identified, with the highest plasma levels observed when quercetin was provided in wine (Goldberg et al., 2003).”